HomeCompareLMLB vs JNJ

LMLB vs JNJ: Dividend Comparison 2026

LMLB yields 20.51% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 LMLB wins by $55.3K in total portfolio value
10 years
LMLB
LMLB
● Live price
20.51%
Share price
$9.75
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$75.4K
Annual income
$7,115.89
Full LMLB calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — LMLB vs JNJ

📍 LMLB pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodLMLBJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, LMLB + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
LMLB pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LMLB
Annual income on $10K today (after 15% tax)
$1,743.64/yr
After 10yr DRIP, annual income (after tax)
$6,048.51/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, LMLB beats the other by $5,344.89/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LMLB + JNJ for your $10,000?

LMLB: 50%JNJ: 50%
100% JNJ50/50100% LMLB
Portfolio after 10yr
$47.7K
Annual income
$3,971.84/yr
Blended yield
8.33%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

LMLB
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LMLB buys
0
JNJ buys
0
No recent congressional trades found for LMLB or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricLMLBJNJ
Forward yield20.51%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$75.4K$20.0K
Annual income after 10y$7,115.89$827.78
Total dividends collected$43.4K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: LMLB vs JNJ ($10,000, DRIP)

YearLMLB PortfolioLMLB Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$12,751$2,051.35$10,676$355.77+$2.1KLMLB
2$16,089$2,444.62$11,407$389.39+$4.7KLMLB
3$20,097$2,882.63$12,198$426.53+$7.9KLMLB
4$24,870$3,365.32$13,056$467.62+$11.8KLMLB
5$30,502$3,891.98$13,987$513.12+$16.5KLMLB
6$37,099$4,461.22$14,998$563.56+$22.1KLMLB
7$44,767$5,071.02$16,098$619.52+$28.7KLMLB
8$53,619$5,718.83$17,295$681.69+$36.3KLMLB
9$63,774$6,401.60$18,599$750.82+$45.2KLMLB
10$75,354$7,115.89$20,022$827.78+$55.3KLMLB

LMLB vs JNJ: Complete Analysis 2026

LMLBStock

The investment seeks to provide two times leveraged long exposure to the compounded monthly performance of the Wells Fargo Master Limited Partnership ex Energy Index. The index is designed to measure the performance of all non-energy master limited partnerships ("MLPs") listed on the New York Stock Exchange ("NYSE"), NYSE MKT or NASDAQ with market capitalization of at least $100 million. The Securities seek to approximate the monthly returns that might be available to investors through a leveraged "long" investment in the index constituent securities.

Full LMLB Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this LMLB vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LMLB vs SCHDLMLB vs JEPILMLB vs OLMLB vs KOLMLB vs MAINLMLB vs ABBVLMLB vs MRKLMLB vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.